Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

By R. Pieterman, J. V. van Putten, J. Meuzelaar, E. Mooyaart, W. Vaalburg, G. Köeter, Vaclav Fidler, J. Pruim, H. Groen. New England Journal of Medicine, 2000

1,148 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/650437b7024c8aebb0ddfe3d41fe1a0a40e11dd6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Graus
2. R. Wahl
3. Jean-Yves Delattre
4. J. Fletcher
5. M. Gorman
6. F. Keime-Guibert
7. R. Reñé
8. B. Benyahia

Citations in the corpus

• Recommendations on the Use of 18F-FDG PET in Oncology (2008, background): “Accurate staging is essential because distant metastases and metastases to mediastinal lymph nodes have a crucial impact on the prognosis of non–small-cell lung cancer, making accurate staging fundamental for selecting the best therapy (72).”
• Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. (2001, background): “…particularly mediastinal involvement, the most common situation in PEM patients (Chartrand-Lefebvre et al., 1998), when other tests are negative (Pieterman et al., 2000) and should be carried out in PEM patients when cancer is not found by conventional radiological procedures (Antoine et al.,…”